Comparing Buprenorphine vs Buprenorphine / Naloxone
| Buprenorphine | Buprenorphine / naloxone |
|
|---|
| Buprenorphine | Buprenorphine / naloxone |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Buprenorphine is a potent analgesic that should be only used to treat moderate to severe pain or for the treatment of opioid addiction under strict conditions. Different formulations of the drug have... View more |
Prescription only
Buprenorphine/naloxone is a combination opioid/opioid antagonist tablet which helps to suppress opioid withdrawal symptoms and is used for the maintenance treatment of opioid drug dependence... View more |
Related suggestions Opiate Dependence
|
|||||||||||||||
| More about Buprenorphine | More about Buprenorphine / naloxone | ||||||||||||||||
| Generic Status | |||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Buprenorphine has an average rating of 6.6 out of 10 from a total of 1016 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 27% reported a negative effect. |
Buprenorphine / naloxone has an average rating of 7.8 out of 10 from a total of 1092 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
Commonly reported side effects include:
See also: buprenorphine side effects in more detail. |
Commonly reported side effects include:
See also: buprenorphine / naloxone side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all buprenorphine prices |
View all buprenorphine / naloxone prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Belbuca, Buprenex, Butrans, Sublocade | Suboxone, Zubsolv | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
48 hours |
37 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 656 drugs are known to interact with buprenorphine:
|
A total of 661 drugs are known to interact with buprenorphine / naloxone:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|||||||||||||||||
| First Approval Date | |||||||||||||||||
|
October 08, 2002 |
October 08, 2002 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.